Contact Us 
Subscribe Us
The genomic data set comprises whole genome sequences of 10,000 individuals from diverse Indian populations
India has achieved a groundbreaking milestone in genomics with the launch of its own genomic data set and the Indian Biological Data Centre (IBDC) portals, making 10,000 whole genome samples accessible globally. Union Minister of State for Science and Technology Jitendra Singh, announced the launch during the Genome India Data Conclave at Vigyan Bhavan on Thursday(January 9, 2025), marking India’s transition to self-reliance in genomic research.
Prime Minister Narendra Modi extended his congratulations via a video message, lauding the scientific community for their contribution to India’s genomic revolution. He remarked, “This initiative is a defining moment in India’s biotechnology landscape, propelling the nation to the forefront of genetic research and innovation.”
A Monumental Achievement in Genomics
The genomic data set, developed under the GenomeIndia Project led by the Department of Biotechnology (DBT), comprises whole genome sequences of 10,000 individuals from diverse Indian populations. This resource, archived at the IBDC, is now available for researchers worldwide, paving the way for advancements in personalised medicine and genetic research.
Addressing the event, Singh emphasised the significance of this achievement: “India is no longer dependent on foreign genomic data. This indigenous resource will enable researchers to study genetic variations specific to Indian demographics and develop tailored genomic tools and healthcare solutions.”
Singh also unveiled the Framework for Exchange of Data (FeED) Protocols, ensuring transparent and responsible data sharing under the Biotech-PRIDE Guidelines, introduced in 2021. These protocols aim to maintain the ethical and secure exchange of high-quality, nation-specific data.
Boosting India’s Bioeconomy
India’s bioeconomy has witnessed remarkable growth, surging from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030. Singh attributed this progress to visionary leadership and the proactive policies of the Indian government, including the recently launched Bio E3 Policy, which aims to establish India as a global leader in biotechnology.
India now ranks 12th globally in biotechnology and 3rd in the Asia-Pacific region. The rapid expansion of biotech startups—from 50 in 2014 to over 8,500 in 2023—underscores India’s potential to revolutionize the global bioeconomy.
The genomic data set is expected to have far-reaching applications across healthcare, agriculture, and industrial research. Prof. Ajay Kumar Sood, Principal Scientific Adviser to the Government of India, highlighted its transformative potential: “This data will not only help prevent and treat genetic disorders but also provide valuable insights for sustainable agricultural practices and environmental research.”
The initiative aims to tackle hereditary diseases, including sickle cell anemia, which disproportionately affects tribal communities in India. The GenomeIndia Project’s comprehensive genetic study will help develop targeted treatments and improve healthcare outcomes for specific populations.
Singh announced an ambitious target to sequence 10 million genomes in the future, further accelerating India’s advancements in genomics and personalized medicine. Collaborations with institutions such as Tata Memorial Hospital are also being explored to enrich the data set.
Prime Minister Modi’s Vision for a Bio-Economy
In his address, Prime Minister Modi highlighted the synergy between biotechnology and biomass as a foundation for a sustainable bioeconomy. “The Genome India Project exemplifies the integration of cutting-edge science with India’s cultural and genetic diversity,” he stated.
The Prime Minister also emphasized India’s evolving role as a major pharma hub, citing revolutionary steps in public healthcare, including free treatment for millions through the Ayushman Bharat scheme and affordable medicines via Jan Aushadhi Kendras.
India’s Growing Research Ecosystem
The Genome India Project is part of a broader effort to establish a robust research ecosystem in India. The government has created initiatives such as Atal Tinkering Labs and Atal Incubation Centers to foster innovation among students and young researchers.
Additionally, the "One Nation One Subscription" initiative ensures cost-free access to prestigious global journals for Indian students and researchers, further enhancing India’s position as a knowledge hub.
Global Impact and Collaboration
India’s genomic data set represents a significant contribution to global research. It positions the country as a key player in addressing global challenges, from genetic disorders to sustainable development.
Dr. Rajesh S. Gokhale, Secretary of DBT, noted, “With this genomic data, India can lead in developing vaccines, understanding genetic disorders, and advancing mRNA technology.” Dr. Rajiv Bahl, Director General of ICMR, and other eminent scientists highlighted the importance of collaborative efforts in realizing the project’s potential.
The launch of the Indian Genomic Data Set and IBDC Portals underscores India’s emergence as a global leader in genomics and biotechnology. By integrating advanced research with ethical and inclusive policies, the initiative marks a transformative step towards a sustainable and innovative bioeconomy.
As Prime Minister Modi aptly stated, “The world looks to India for solutions to global problems. This is both a responsibility and an opportunity for future generations.” The GenomeIndia Project is set to shape the future of genetic research, empowering India to lead the next scientific revolution.
Prime Minister Narendra Modi extended his congratulations via a video message, lauding the scientific community for their contribution to India’s genomic revolution. He remarked, “This initiative is a defining moment in India’s biotechnology landscape, propelling the nation to the forefront of genetic research and innovation.”
A Monumental Achievement in Genomics
The genomic data set, developed under the GenomeIndia Project led by the Department of Biotechnology (DBT), comprises whole genome sequences of 10,000 individuals from diverse Indian populations. This resource, archived at the IBDC, is now available for researchers worldwide, paving the way for advancements in personalised medicine and genetic research.
Addressing the event, Singh emphasised the significance of this achievement: “India is no longer dependent on foreign genomic data. This indigenous resource will enable researchers to study genetic variations specific to Indian demographics and develop tailored genomic tools and healthcare solutions.”
Singh also unveiled the Framework for Exchange of Data (FeED) Protocols, ensuring transparent and responsible data sharing under the Biotech-PRIDE Guidelines, introduced in 2021. These protocols aim to maintain the ethical and secure exchange of high-quality, nation-specific data.
Boosting India’s Bioeconomy
India’s bioeconomy has witnessed remarkable growth, surging from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030. Singh attributed this progress to visionary leadership and the proactive policies of the Indian government, including the recently launched Bio E3 Policy, which aims to establish India as a global leader in biotechnology.
India now ranks 12th globally in biotechnology and 3rd in the Asia-Pacific region. The rapid expansion of biotech startups—from 50 in 2014 to over 8,500 in 2023—underscores India’s potential to revolutionize the global bioeconomy.
The genomic data set is expected to have far-reaching applications across healthcare, agriculture, and industrial research. Prof. Ajay Kumar Sood, Principal Scientific Adviser to the Government of India, highlighted its transformative potential: “This data will not only help prevent and treat genetic disorders but also provide valuable insights for sustainable agricultural practices and environmental research.”
The initiative aims to tackle hereditary diseases, including sickle cell anemia, which disproportionately affects tribal communities in India. The GenomeIndia Project’s comprehensive genetic study will help develop targeted treatments and improve healthcare outcomes for specific populations.
Singh announced an ambitious target to sequence 10 million genomes in the future, further accelerating India’s advancements in genomics and personalized medicine. Collaborations with institutions such as Tata Memorial Hospital are also being explored to enrich the data set.
Prime Minister Modi’s Vision for a Bio-Economy
In his address, Prime Minister Modi highlighted the synergy between biotechnology and biomass as a foundation for a sustainable bioeconomy. “The Genome India Project exemplifies the integration of cutting-edge science with India’s cultural and genetic diversity,” he stated.
The Prime Minister also emphasized India’s evolving role as a major pharma hub, citing revolutionary steps in public healthcare, including free treatment for millions through the Ayushman Bharat scheme and affordable medicines via Jan Aushadhi Kendras.
India’s Growing Research Ecosystem
The Genome India Project is part of a broader effort to establish a robust research ecosystem in India. The government has created initiatives such as Atal Tinkering Labs and Atal Incubation Centers to foster innovation among students and young researchers.
Additionally, the "One Nation One Subscription" initiative ensures cost-free access to prestigious global journals for Indian students and researchers, further enhancing India’s position as a knowledge hub.
Global Impact and Collaboration
India’s genomic data set represents a significant contribution to global research. It positions the country as a key player in addressing global challenges, from genetic disorders to sustainable development.
Dr. Rajesh S. Gokhale, Secretary of DBT, noted, “With this genomic data, India can lead in developing vaccines, understanding genetic disorders, and advancing mRNA technology.” Dr. Rajiv Bahl, Director General of ICMR, and other eminent scientists highlighted the importance of collaborative efforts in realizing the project’s potential.
The launch of the Indian Genomic Data Set and IBDC Portals underscores India’s emergence as a global leader in genomics and biotechnology. By integrating advanced research with ethical and inclusive policies, the initiative marks a transformative step towards a sustainable and innovative bioeconomy.
As Prime Minister Modi aptly stated, “The world looks to India for solutions to global problems. This is both a responsibility and an opportunity for future generations.” The GenomeIndia Project is set to shape the future of genetic research, empowering India to lead the next scientific revolution.
Contact Us 
Subscribe 
News Letter 
